You are viewing a single comment's thread from:

RE: LeoThread 2025-07-01 12:43

in LeoFinance3 months ago

Part 7/9:

Christine emphasized that not all sectors are winner-takes-all, allowing for multiple investment opportunities within the same healthcare subfield. This approach has proven successful, as illustrated by their discussions on CAR-T therapy companies like Kite Pharma and Juno Therapeutics, where both ended up being profitable despite initial disagreements on which stock was the better pick.

Reassessing the Meaning of 'Expensive' Stocks